Your browser doesn't support javascript.
loading
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
Huang, Kuan-Ying A; Zhou, Daming; Tan, Tiong Kit; Chen, Charles; Duyvesteyn, Helen M E; Zhao, Yuguang; Ginn, Helen M; Qin, Ling; Rijal, Pramila; Schimanski, Lisa; Donat, Robert; Harding, Adam; Gilbert-Jaramillo, Javier; James, William; Tree, Julia A; Buttigieg, Karen; Carroll, Miles; Charlton, Sue; Lien, Chia-En; Lin, Meei-Yun; Chen, Cheng-Pin; Cheng, Shu-Hsing; Chen, Xiaorui; Lin, Tzou-Yien; Fry, Elizabeth E; Ren, Jingshan; Ma, Che; Townsend, Alain R; Stuart, David I.
Afiliação
  • Huang KA; Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Zhou D; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Tan TK; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Chen C; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
  • Duyvesteyn HME; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Zhao Y; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Ginn HM; Temple University, Philadelphia, PA 19122, USA.
  • Qin L; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
  • Rijal P; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
  • Schimanski L; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
  • Donat R; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
  • Harding A; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Gilbert-Jaramillo J; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • James W; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Tree JA; Sir William Dunn School of Pathology, South Park Road, University of Oxford, UK.
  • Buttigieg K; Sir William Dunn School of Pathology, South Park Road, University of Oxford, UK.
  • Carroll M; Sir William Dunn School of Pathology, South Park Road, University of Oxford, UK.
  • Charlton S; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
  • Lien CE; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
  • Lin MY; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
  • Chen CP; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
  • Cheng SH; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Chen X; Institute of Public Health, National Yang-Ming Chiao Tung University, Taipei, Taiwan.
  • Lin TY; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Fry EE; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, and National Yang-Ming University, Taipei, Taiwan.
  • Ren J; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, and Taipei Medical University, Taipei, Taiwan.
  • Ma C; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Townsend AR; Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Stuart DI; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
Theranostics ; 12(1): 1-17, 2022.
Article em En | MEDLINE | ID: mdl-34987630
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Anticorpos Monoclonais Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Anticorpos Monoclonais Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan